Author details

Full Name

Sara Nasser

Affiliation

ORCID

Career Start Year

2011

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
35131913	Nerve sparing systematic lymph node dissection (para-aortic region): a technique for enhanced functional outcomes after gynecological cancer surgeries.	International Journal of Gynecological Cancer	2022
36620574	Can a morphological description of the peritoneal carcinomatosis in advanced ovarian cancer add prognostic information? Analysis of 1686 patients of the tumor bank ovarian cancer.		2022
35134130	Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma.	Blood	2022
34610968	Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion.	Cancer Res	2021
33826614	Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial.	PLoS One	2021
33813410	Prognostic Value and Therapeutic Implications of Pleural Carcinosis and Malignant Pleural Effusion in Advanced Epithelial Ovarian Cancer.	Anticancer Research	2021
33361458	Subspecialty training in Europe: a report by the European Network of Young Gynaecological Oncologists.	International Journal of Gynecological Cancer	2021
32727500	Unmet family planning needs among female refugees and asylum seekers in Germany - is free access to family planning services enough? Results of a cross-sectional study.	Reproductive Health	2020
33246921	Role of predictive markers for severe postoperative complications in gynecological cancer surgery: a prospective study (RISC-Gyn Trial).	International Journal of Gynecological Cancer	2020
30718317	A report on the Marrakech International Women's Cancer Days: dialogs and implications.	International Journal of Gynecological Cancer	2019
31881020	Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomas.	PLoS One	2019
30861105	A pilot precision medicine trial for children with diffuse intrinsic pontine glioma-PNOC003: A report from the Pacific Pediatric Neuro-Oncology Consortium.	Int J Cancer	2019
31416612	OVQUEST - Life after the diagnosis and treatment of ovarian cancer - An international survey of symptoms and concerns in ovarian cancer survivors.	Gynecologic Oncology	2019
29074604	Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive Glioblastoma.	Clin Cancer Res	2018
30207101	Checkpoint-inhibition in ovarian cancer: rising star or just a dream?	Journal of Gynecologic Oncology	2018
30278996	Impact of right upper quadrant cytoreductive techniques with extensive liver mobilization on postoperative hepatic function and risk of liver failure in patients with advanced ovarian cancer.	Gynecologic Oncology	2018
28057415	Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib.	Clin Genitourin Cancer	2017
28861808	A Review of Thoracic and Mediastinal Cytoreductive Techniques in Advanced Ovarian Cancer: Extending the Boundaries.	Annals of Surgical Oncology	2017
28373299	Integrated genomic analyses reveal frequent <i>TERT</i> aberrations in acral melanoma.	Genome Res	2017
27586894	Correlation of pre-operative CT findings with surgical & histological tumor dissemination patterns at cytoreduction for primary advanced and relapsed epithelial ovarian cancer: A retrospective evaluation.	Gynecologic Oncology	2016
27094764	A somatic reference standard for cancer genome sequencing.	Sci Rep	2016
28003660	Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers.	Sci Rep	2016
27630347	Feasibility and Safety of Laparoscopic Total Mesometrial Resection in Early-stage Cervical Cancer.	Anticancer Research	2016
26026105	AGO Score As a Predictor of Surgical Outcome at Secondary Cytoreduction in Patients with Ovarian Cancer.	Anticancer Research	2015
25592568	An integrated framework for reporting clinically relevant biomarkers from paired tumor/normal genomic and transcriptomic sequencing data in support of clinical trials in personalized medicine.	Pac Symp Biocomput	2015
24625924	Genomic view of bipolar disorder revealed by whole genome sequencing in a genetic isolate.	PLoS Genet	2014
25312441	A rare case of ovarian cancer in pregnancy complicated by pulmonary embolus and myocardial infarction: management dilemmas.	Journal of Surgical Case Reports	2014
24403495	A case of primary peritoneal carcinoma: evidence for a precursor in the fallopian tube.	Anticancer Research	2014
24418928	Simultaneous characterization of somatic events and HPV-18 integration in a metastatic cervical carcinoma patient using DNA and RNA sequencing.	Int J Gynecol Cancer	2014
24489661	Integrated genomic and epigenomic analysis of breast cancer brain metastasis.	PLoS One	2014
24550739	Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma.	PLoS Genet	2014
23459507	Comparison of Analysis Tools for miRNA High Throughput Sequencing Using Nerve Crush as a Model.	Front Genet	2013
22745829	miRNA expression profiling in migrating glioblastoma cells: regulation of cell migration and invasion by miR-23b via targeting of Pyk2.	PLoS ONE	2012
21805824	Biomarkers associated with metastasis of lung cancer to brain predict patient survival.	International Journal of Data Mining and Bioinformatics	2011
21448905	MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration.	International Journal of Cancer	2011
21489222	Context-specific gene regulatory networks subdivide intrinsic subtypes of breast cancer.	BMC Bioinformatics	2011